Publicaciones (40) Publicaciones de SALVADOR OYONARTE GÓMEZ

2022

  1. Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 9, pp. 507-516

2021

  1. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  2. Generation of a novel model of bioengineered human oral mucosa with increased vascularization potential

    Journal of Periodontal Research, Vol. 56, Núm. 6, pp. 1116-1131

  3. SARS-CoV-2 neutralising antibody testing in Europe: Towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

    Eurosurveillance, Vol. 27

  4. Unprecedented increase of West Nile virus neuroinvasive disease, Spain, summer 2020

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 26, Núm. 19

2020

  1. Evaluación diagnóstica de competencias en un modelo de aprendizaje+servicio en el grado de Medicina

    Actualidad médica, Tomo 105, Núm. 809, pp. 35-38

  2. Evaluation of myopic cornea lenticules. A histochemical and clinical correlation: Histology of the myopic cornea

    Experimental Eye Research, Vol. 196

2019

  1. West nile and usutu virus infections and challenges to blood safety in the European Union

    Emerging Infectious Diseases, Vol. 25, Núm. 6, pp. 1050-1057

2018

  1. West nile virus outbreak in humans and epidemiological surveillance, west Andalusia, Spain, 2016

    Eurosurveillance, Vol. 23, Núm. 14

2017

  1. Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections

    Vox Sanguinis, Vol. 112, Núm. 4, pp. e1-e21

  2. Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections: summary

    Vox Sanguinis, Vol. 112, Núm. 4, pp. 388-396

2016

  1. Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?

    Cytotherapy, Vol. 18, Núm. 7, pp. 809-815

2012

  1. Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary aspergillosis infection

    PLoS ONE, Vol. 7, Núm. 2

2010

  1. Predicción de anemia fetal por isoinmunización tras transfusiones intrauterinas. Revisión de los casos tratados en nuestra unidad

    Progresos de Obstetricia y Ginecologia, Vol. 53, Núm. 9, pp. 335-340

  2. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis

    International Journal of Immunopathology and Pharmacology, Vol. 23, Núm. 2, pp. 423-436

  3. Transfusión de plaquetas en el recién nacido

    Acta pediátrica española, Vol. 68, Núm. 10, pp. 487-492

  4. Transfusión de plaquetas en el recién nacido

    Acta Pediatrica Espanola, Vol. 68, Núm. 10, pp. 487-492

2008

  1. Current clinical management of anti-Kell alloimmunization in pregnancy

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 136, Núm. 2, pp. 151-154

  2. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients

    Cytokine, Vol. 41, Núm. 3, pp. 268-278

  3. HNA-1a, HNA-1b and HNA-1c gene frequencies in Argentineans

    Tissue Antigens, Vol. 71, Núm. 5, pp. 475-477